Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.81 USD | +1.12% | -7.65% | -48.32% |
Business Summary
Number of employees: 17
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Therapeutics
100.0
%
| 0 | nan % | 12 | 100.0 % | - |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 0 | nan % | 12 | 100.0 % | - |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Charles Theuer
CEO | Chief Executive Officer | 60 | 01/06/01 |
Scott Brown
DFI | Director of Finance/CFO | 43 | 01/15/01 |
James L. Freddo
CTO | Chief Tech/Sci/R&D Officer | 69 | 01/20/01 |
Brenda Marczi
LAW | General Counsel | - | 20/21/20 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Martin Mattingly
BRD | Director/Board Member | 66 | 26/14/26 |
Director/Board Member | 54 | 19/20/19 | |
Stephen Worland
BRD | Director/Board Member | 66 | 25/15/25 |
Rainer Twiford
BRD | Director/Board Member | 71 | 01/08/01 |
William LaRue
BRD | Director/Board Member | 73 | 01/14/01 |
Charles Theuer
CEO | Chief Executive Officer | 60 | 01/06/01 |
Carol Lam
BRD | Director/Board Member | 64 | 12/21/12 |
Director/Board Member | 60 | 02/21/02 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 2,275,226 | 2,216,192 ( 97.41 %) | 0 | 97.41 % |
Company contact information
TRACON Pharmaceuticals, Inc.
4350 La Jolla Village Drive Suite 800
92122-1243, San Diego
+
http://www.traconpharma.comSector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-48.32% | 4.12M | |
-4.66% | 86.13B | |
+1.32% | 39.82B | |
-19.27% | 30.42B | |
+57.86% | 25.23B | |
-16.09% | 15.35B | |
-9.14% | 11.95B | |
-17.69% | 11.6B | |
-43.00% | 11.51B | |
+5.24% | 8.71B |
- Stock Market
- Equities
- TCON Stock
- Company TRACON Pharmaceuticals, Inc.